GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Cash Flow from Investing

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Cash Flow from Investing : HK$-129 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Dec. 2024, Zhongzhi Pharmaceutical Holdings spent HK$47 Mil on purchasing property, plant, equipment. It gained HK$3 Mil from selling property, plant, and equipment. It spent HK$0 Mil on purchasing business. It gained HK$0 Mil from selling business. It spent HK$5 Mil on purchasing investments. It gained HK$6 Mil from selling investments. It paid HK$1Mil for net Intangibles purchase and sale. And it received HK$3 Mil from other investing activities. In all, Zhongzhi Pharmaceutical Holdings spent HK$42 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Dec. 2024.


Zhongzhi Pharmaceutical Holdings Cash Flow from Investing Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Cash Flow from Investing Chart

Zhongzhi Pharmaceutical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -296.86 -166.50 14.94 -221.77 -128.19

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.00 -93.70 -128.07 -87.20 -41.71

Zhongzhi Pharmaceutical Holdings Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Zhongzhi Pharmaceutical Holdings's Cash Flow from Investing for the fiscal year that ended in Dec. 2024 is calculated as:

Zhongzhi Pharmaceutical Holdings's Cash Flow from Investing for the quarter that ended in Dec. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-129 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhongzhi Pharmaceutical Holdings  (HKSE:03737) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Zhongzhi Pharmaceutical Holdings's purchase of property, plant, equipment for the six months ended in Dec. 2024 was HK$-47 Mil. It means Zhongzhi Pharmaceutical Holdings spent HK$47 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Zhongzhi Pharmaceutical Holdings's sale of property, plant, equipment for the six months ended in Dec. 2024 was HK$3 Mil. It means Zhongzhi Pharmaceutical Holdings gained HK$3 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Zhongzhi Pharmaceutical Holdings's purchase of business for the six months ended in Dec. 2024 was HK$0 Mil. It means Zhongzhi Pharmaceutical Holdings spent HK$0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Zhongzhi Pharmaceutical Holdings's sale of business for the six months ended in Dec. 2024 was HK$0 Mil. It means Zhongzhi Pharmaceutical Holdings gained HK$0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Zhongzhi Pharmaceutical Holdings's purchase of investment for the six months ended in Dec. 2024 was HK$-5 Mil. It means Zhongzhi Pharmaceutical Holdings spent {stock_data.stock.currency_symbol}}5 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Zhongzhi Pharmaceutical Holdings's sale of investment for the six months ended in Dec. 2024 was HK$6 Mil. It means Zhongzhi Pharmaceutical Holdings gained HK$6 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Zhongzhi Pharmaceutical Holdings's net Intangibles purchase and sale for the six months ended in Dec. 2024 was HK$-1 Mil. It means Zhongzhi Pharmaceutical Holdings paid HK$1 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Zhongzhi Pharmaceutical Holdings's cash from discontinued investing activities for the six months ended in Dec. 2024 was 0 Mil. It means Zhongzhi Pharmaceutical Holdings paid HK$0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Zhongzhi Pharmaceutical Holdings's cash from other investing activities for the six months ended in Dec. 2024 was HK$3 Mil. It means Zhongzhi Pharmaceutical Holdings received HK$3 Mil from other investing activities.


Zhongzhi Pharmaceutical Holdings Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongzhi Pharmaceutical Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN
Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations are divided into two segments, namely Pharmaceutical manufacturing, and Operation of chain pharmacies. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing, and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. It derives a majority of its revenue from the PRC.
Executives
Jiang Li Xia 2202 Interest of your spouse
Lai Zhi Tian 2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited 2101 Beneficial owner
Cheng Jin Le 2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited 2101 Beneficial owner
Novich Positioning Investment (cayman) Limited 2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership 2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings Headlines

No Headlines